Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionSowell Financial Services LLC
Latest Disclosed Ownership16,614 shares
Latest Disclosed Value $ 1,705,733
Sowell Financial Services LLC reports 6.17% decrease in ownership of ABL / Abbott Laboratories

On April 20, 2026 - Sowell Financial Services LLC filed a 13F-HR form disclosing ownership of 16,614 shares of Abbott Laboratories (DE:ABL) valued at $1,475,655 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 17,707 shares of Abbott Laboratories. This represents a change in shares of -6.17% during the quarter. The current value of the position is $1,249,705 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 16,614 -1,093 -6.17 1,706 -23.13 0.0631
2026-01-21 2025-12-31 13F ABBOTT LABS COM 002824100 17,707 -259 -1.44 2,219 -7.81 0.0815
2025-10-17 2025-09-30 13F ABBOTT LABS COM 002824100 17,966 -5,924 -24.80 2,406 -25.95 0.0923
2025-07-14 2025-06-30 13F ABBOTT LABS COM 002824100 23,890 108 0.45 3,249 3.01 0.1323
2025-04-17 2025-03-31 13F ABBOTT LABS COM 002824100 23,782 -8,301 -25.87 3,155 -13.07 0.1436
2025-02-07 2024-12-31 13F ABBOTT LABS COM 002824100 32,083 5,576 21.04 3,629 20.05 0.1908
2024-10-04 2024-09-30 13F ABBOTT LABS COM 002824100 26,507 -1,073 -3.89 3,022 5.44 0.1404
2024-08-13 2024-06-30 13F ABBOTT LABS COM 002824100 27,580 -3,500 -11.26 2,866 -18.88 0.1369
2024-05-03 2024-03-31 13F ABBOTT LABS COM 002824100 31,080 7,050 29.34 3,533 33.57 0.1667
2024-01-24 2023-12-31 13F ABBOTT LABS COM 002824100 24,030 1,319 5.81 2,645 20.23 0.1433
2023-11-08 2023-09-30 13F ABBOTT LABS COM 002824100 22,711 6,433 39.52 2,200 23.94 0.1381
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 16,278 1,258 8.38 1,775 177,400.00 0.0989
2023-05-12 2023-03-31 13F ABBOTT LABS STOCK 002824100 15,020 -261 -1.71 2 0.00 0.1174
2023-02-09 2022-12-31 13F Abbott Laboratories Stock 002824100 15,281 15,281 2 0.1086
2022-08-15 2022-06-30 13F ABBOTT LABS Stock 002824100 0 -15,265 -100.00 0 -100.00
2022-05-13 2022-03-31 13F ABBOTT LABS Stock 002824100 15,265 -5,713 -27.23 1,751 -40.70 0.3059
2022-02-09 2021-12-31 13F ABBOTT LABS COM Stock 002824100 20,978 -2,334 -10.01 2,953 7.23 0.1693
2021-11-04 2021-09-30 13F ABBOTT LABS COM Stock 002824100 23,312 -2,638 -10.17 2,754 -8.44 0.1860
2021-08-05 2021-06-30 13F ABBOTT LABS COM Stock 002824100 25,950 -1,950 -6.99 3,008 -9.23 0.1993
2021-05-07 2021-03-31 13F ABBOTT LABS COM Stock 002824100 27,900 3,345 13.62 3,314 23.29 0.1153
2021-01-13 2020-12-31 13F ABBOTT LABS COM COM 002824100 24,555 4,804 24.32 2,688 25.02 0.1148
2020-11-12 2020-09-30 13F ABBOTT LABS COM COM 002824100 19,751 -8,851 -30.95 2,150 -17.78 0.1074
2020-08-13 2020-06-30 13F ABBOTT LABS COM Stock 002824100 28,602 -22,399 -43.92 2,615 -35.01 0.1437
2020-05-12 2020-03-31 13F ABBOTT LABS COM Stock 002824100 51,001 16,351 47.19 4,024 33.69 0.2978
2020-02-07 2019-12-31 13F ABBOTT LABS COM Stock 002824100 34,650 -628 -1.78 3,010 1.96 0.2294
2019-11-14 2019-09-30 13F ABBOTT LABS COM COM 002824100 35,278 19,299 120.78 2,952 131.17 0.2439
2019-05-15 2019-03-31 13F ABBOTT LABS COM Stock 002824100 15,979 -442 -2.69 1,277 7.49 0.1426
2019-03-05 2018-12-31 13F ABBOTT LABS COM 002824100 16,421 1,876 12.90 1,188 11.34 0.1683
2018-11-13 2018-09-30 13F ABBOTT LABS COM 002824100 14,545 -44 -0.30 1,067 15.35 0.1549
2018-08-14 2018-06-30 13F ABBOTT LABS COM 002824100 14,589 334 2.34 925 12.12 0.1963
2018-05-10 2018-03-31 13F ABBOTT LABS COM 002824100 14,255 -167 -1.16 825 -3.17 0.2062
2018-01-29 2017-12-31 13F ABBOTT LABS COM 002824100 14,422 437 3.12 852 12.85 0.2083
2017-11-07 2017-09-30 13F ABBOTT LABS COM 002824100 13,985 574 4.28 755 15.09 0.1968
2017-08-14 2017-06-30 13F ABBOTT LABS COM 002824100 13,411 288 2.19 656 14.89 0.1862
2017-05-31 2017-03-31 13F ABBOTT LABS COM 002824100 13,123 760 6.15 571 5.74 0.1686
2017-02-27 2016-12-31 13F Abbott Laboratories COM 002824100 12,363 12,363 540 0.1808
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.